Cannon Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$699K Buy
7,220
+1,202
+20% +$142K 0.41% 63
2026
Q2
$663K Buy
+6,018
New +$729K 0.4% 56

Other funds holding INSM

Cannon Advisors's INSM Position: Q3 2026 in Review

Cannon Advisors increased its Insmed (INSM) stake by 20% in Q3 2026, buying an estimated $142K and bringing the position to 7,220 shares worth $699K. The position accounts for 0.41% of the portfolio, ranked #63.

Cannon Advisors first reported a position in INSM in Q2 2026 and has held it in 2 quarters since. 703 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Cannon Advisors held 7,220 shares of Insmed worth $699K as of Q3 2026.
  • Cannon Advisors bought 1,202 Insmed shares in Q3 2026, an estimated $142K.
  • Insmed made up 0.41% of Cannon Advisors's portfolio in Q3 2026, its #63 holding.
  • Cannon Advisors first reported a position in Insmed in Q2 2026 and has held it in 2 quarters since.
  • 703 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Cannon Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.